Founded by Dr. Herb Sun, former Director of Orthopaedic Research and Professor of Orthopaedic Surgery at Albert Einstein College of Medicine, New York R&D Center for Translational Medicine and Therapeutics (NY.TmT) is an R&D company pursuing commercialization of therapies addressing musculoskeletal diseases and disorders, such as tendinopathy and osteoarthritis. In particular, foxus is on tendinopathy - a painful, chronic disease of the tendon with degeneration of the tissue and cellular structures, which often leads to tendon rupture. Current development of miR-T1, a novel microRNA-based therapeutic, that aims to provide a disease-modifying therapy for tendinopathy by restoring tendon function and alleviating pain.
